A detailed history of Oxford Financial Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Oxford Financial Group LTD holds 5,598 shares of ABBV stock, worth $936,265. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,598
Previous 5,422 3.25%
Holding current value
$936,265
Previous $840,000 21.31%
% of portfolio
0.07%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $28,128 - $32,049
176 Added 3.25%
5,598 $1.02 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $24,080 - $27,119
175 Added 3.34%
5,422 $840,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $39,809 - $46,085
-298 Reduced 5.37%
5,247 $782,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $353,669 - $440,118
2,669 Added 92.8%
5,545 $747,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $29,500 - $33,974
204 Added 7.63%
2,876 $458,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $369,564 - $443,204
2,672 New
2,672 $432,000
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $13,211 - $16,796
96 Added 3.99%
2,505 $384,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $4,091 - $5,076
-31 Reduced 1.27%
2,409 $391,000
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $19,229 - $24,331
179 Added 7.92%
2,440 $330,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $207,054 - $235,037
-1,946 Reduced 46.26%
2,261 $244,000
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $95,741 - $106,661
-910 Reduced 17.78%
4,207 $474,000
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $17,186 - $18,920
-168 Reduced 3.18%
5,117 $554,000
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $12,314 - $16,626
153 Added 2.98%
5,285 $566,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $2,147 - $2,520
25 Added 0.49%
5,132 $450,000
Q2 2020

Aug 05, 2020

SELL
$73.37 - $98.18 $953 - $1,276
-13 Reduced 0.25%
5,107 $501,000
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $330,240 - $500,684
5,120 New
5,120 $390,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Oxford Financial Group LTD Portfolio

Follow Oxford Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.